バクロフェンとボトリン毒素A 脳性麻痺の子供のトーン管理における使用: 術前および術後のケアにおける現在の文献と研究ギャップのレビュー
Michael Li1, Naama Rozen2, Kate Wortley3
1Faculty of Medicine, Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
Pediatric neurology
|August 29, 2025
まとめ
このレビューは,脳性麻痺 (CP) の手術におけるボツリン毒素Aの代替案を探求しています. 経口バクロフェンの投与量を増加させることで,現在の治療法よりも副作用が少なくなる可能性を示唆しています.
科学分野:
- 小児整形外科
- 神経科学
- 薬理学について
背景:
- 脳性麻痺 (CP) は,小児の運動障害の主な原因で,しばしば骨格外科手術を必要とする高血圧症を伴う.
- ボトリヌム毒素A (BoNT-A) のような現在の治療法は,一貫性のない有効性と有害性があり,より良い代替品が必要である.
- 経口バクロフェンは,CP関連高血圧症の第一線治療法ですが,手術前補助薬として投与量を最適化することは研究されていません.
研究 の 目的:
- 一般的に使用されている抗性治療の有効性および安全性に関する証拠の見直し: BoNT-A,経口バクロフェン,および内バクロフェン.
- CPの小児における整形外科手術の補助として,経口バクロフェンの投与量を増加させる可能性を評価する.
- CPの手術結果を改善するために,BoNT-Aの潜在的に安全で効果的な代替案を特定する.
主な方法:
- CPの管理のためのBoNT-A,経口バクロフェン,および腸内バクロフェンに関する既存の文献の体系的なレビュー.
- 各治療方法の有効性,安全性,副作用の分析
- 術前の経口バクロフェン投与量の増加に関する理論的な利点と事前の研究の欠如.
主要な成果:
- 業界バイアスと長期的な筋肉形態の変化に関する懸念があるため,矛盾した証拠がBoNT-Aの有効性を支持しています.
- 経口バクロフェンは,CPにおける全般的高血圧症の第一線治療です.
- 手術前でのバクロフェンの投与量増加の影響を調べた研究はありません.
結論:
- 小児の脳卒中手術では 抗性治療の改善が必要です
- 手術前での経口バクロフェンの投与量の増加は,BoNT-Aの有望な,まだ未研究された代替品です.
- 経口バクロフェンをCP手術の補助として増加させるためのさらなる研究が必要である.
さらに関連する動画
関連する概念動画
Depolarizing Blockers: Pharmocokinetics
784
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
784
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
2.2K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
2.2K
Skeletal Muscle Relaxants: Adverse Effects
1.2K
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
1.2K
Skeletal Muscle Relaxants: Therapeutic Uses
1.2K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.2K
Local Anesthetics: Clinical Application as Spinal Anesthesia
2.0K
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
2.0K
Alterations in Muscle Tone ll
27
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
27


